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dilated CMP(APD95)
can. 10-4 M 10-3 M
Intramural Heparin (ug)
3.70 ± 3.69
0.57 ± 0.82
0.13 ± 0.16
0.02 ± 001
Time of Harvest
Immediate
30 minutes
60 minutes
24 hours
ischemic CMP (APD95)
can. 10-4 M 10-3 M
Endo
0.5 HZ 304 ± 18 425 ± 26' 559 ± 23' 297 ± 17 390 ± 20' 457 ± 21'
1.0 HZ 274 ± 17 392 ± 18' 519 ± 27* 255 ± 21 383 ± 19' 405 ± 22'
Epi
0.5 HZ 280 ± 14 368 ± 19' 471 ± 20' 277 ± 17 371 ± 18' 419 ± 23'
10 HZ 250 ± 16 350 ± 20' 435 ± 18' 240 ± 13 367 ± 15' 388 ± 15'
Number of Vessels
4
4
4
4
'p < 0.05 Can. vs. d-Sot
Conclusion: D-Sotalol exhibits highly selective class-III activity under all
studied conditions. The parameters of repolarization were differentially af-
fected in the epicardial and endocardial structures with a maximum effect in
the CAD endocardium. The heterogeneity of the endolepi repolarization pat-
terns was markedly more pronounced in ischemic than in dilated cardiomy-
opathy implying enhanced antiarrhythmic as well as proarrhythmic potential
in chronic ischemic myocardium.
Conclusions: Heparin can be safely delivered to coronary angioplasty sites
using iontophoresis. Although subsequent drug washout occurs rapidly,
small amounts of intramural heparin delivered with this technique persist
for at least 24 hours.
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Local Intracoronary Delivery of Heparin and of a
Somatostatin Analogue (Octreotide) Following
Angioplasty in Man: Evaluation of Efficacy of Delivery
by Radio-Isotopic Technique
Local Intracoronary Delivery
In 37 patients (28 men, 58 ± 10 years) following conventional PTCA heparin
(H) (n = 37) and Octreotide (0) (n = 10) was infused through the Dispatch '"
(Scimed) at the site of angioplasty. Mean drug infusion time was 30 ± 7 min
(range: 7-39 min). Avolume of 16 ± 6 ml (range: 1.4-23.4 mil corresponding
to 1660 ± 656 IU Hand 0.39 ± 0.02 I'-g 0 was infused with a mean pres-
sure of 110 ± 48 mmHg. Radio-isotopic studies with infusion of technetium
labelled H (Tc-99m H; n = 2) or of indium labelled 0 (In-111 0; n = 5) were
performed to assess efficacy of local drug delivery. During infusion a linear
Edoardo Camenzind, Ambroos Reys, Jurgen Ligthart, Willem Bakker, Inge van
GeiJlswijk, Paolo Fioretti, Eric Krenning, Patrick W. Serruys. Departments
Thoraxcentre, Nuclear Medicine and Pharmacy, Erasmus University, Rotterdam,
Netherlands
1772-11 Localized Intracoronary Delivery of Heparin with
Iontophoresis
Joseph F. Mitchel, Michael A. Azrin, Daniel B. Fram, Hamid Feroze, Adel M. Eldin,
Michael Shwedick, David D. Waters, Raymond G. McKay. Hartford Hospital,
University of Connecticut, Hartford, cr
Previous work by our laboratory has demonstrated successful local deliv-
ery of heparin at angioplasty sites with a novel iontophoresis catheter which
uses an applied electric field to selectively move charged drug molecules
into the arterial wall. In order to assess the safety and efficiency of this
technique in the local delivery of heparin in the coronary vasculature, ion-
tophoresis of 3H-heparin was performed in 16 coronary arteries in 7 anes-
thetized pigs. All vessels initially underwent conventional balloon angioplasty
for 60 seconds at 6 atm using standard angioplasty catheters with a balloon-
artery ratio of 1.1 :1. Iontophoresis at 5 mA was then performed with a similar
sized catheter using a heparin concentration of 1000 U/ml, an iontophoretic
membrane balloon pressure of 1 atm, and an iontophoresis time of 90 secs.
Vessels were subsequently harvested at various times up to 24 hours and
counted in a scintillation counter to quantitate intramural heparin deposition
and wash-out.
Results: Heparin iontophoresis in all16 vessels was well tolerated without
change in systemic blood pressure, cardiac rhythm, or coronary angiography.
Intramural drug levels are listed below:
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Heterogenous Repolarization Parameters in Human
Endo- and Epicardial Tissue After Application of
Class-III Agent d-Sotalol in Ischemic and Dilated
Cardiomypathy
Harald Marschang, Thorsten Beyer, Maria Montero, Wolfgang Kubler,
Johannes Brachmann. Department of Cardiology, University of Heidelberg, Germany
Proarrhythmic effects are known as the major limiting factors of antiarrhyth-
mic drug therapy. In class-III compounds proarrhythmia mostly manifests as
Torsade de pointes tachyarrhythmia correlated with EADs and other non-
specific ventricular arrhythmias. The precise underlying mechanism of this
phenomenon and its possible modulation in different pathologic conditions
is still unclear. Intracellular action potentials were recorded by standard mi-
croelectrode techniques from the endo- and epicardial surface of human
myocardial specimens obtained from explanted hearts of patients with is-
chemic and dilated cardiomyopathy undergoing orthotopic heart transplant.
The following electrophysiological parameters were registered: AP ampli-
tude (APA), resting membrane potential (RMP), AP duration at 95% and 50%
repolarization (APD 95 and 50), maximal upstroke velocity (Vmax ) and effec-
tive refractory period (ERP). Values are expressed as mean ± SO.
William J. Groh, James G. Maylie Oregon Health Sciences University, Portland, OR
Myocardial stretch has been shown to shorten action potential duration
(APD) and thus may modulate the efficacy of class III antiarrhythmic agents.
We studied the effect of hypotonic-induced stretch on guinea pig ventricu-
lar myocytes treated with the d-sotalol analogue, E-4031, using a whole-cell
patch clamp technique.
Methods: Myocytes were perfused with normal Tyrode solution [300
mOsmollil at 23°C and dialyzed with a pipette containing (mM): K-Asp 90,
KCI40, NaCI10, MgCI2 1, MgATP 5, HEPES 10, EGTA 10, CaCI2 1, pH 7.1
[310 mOsmolll].
Results: Addition of 10 ILM E-4031 prolonged the APD by 10.1 ± 1.8%
(mean ± SEM), n = 10, P < 0.001. Perfusion with hypotonic (hT) solution [Ty-
rode less 35 mM NaCl, 230 mOsmolli1 + 10 ILM E-4031 induced cell swelling
with width increasing by 38.7 ± 2.7% and length by 6.0 ± 0.7 measured at 5
min, n = 36, p < 0.001. The APD measured at 5 min shortened in hT solution
by 38.7 ± 2.7%, n = 10, p < 0.001. Voltage-clamp studies showed no sig-
nificant change in the Na+, Ca2+, or inward rectifier K+ currents. The slow
component of the delayed rectifier K+ current (lKs) measured during a 5 s de-
polarization to 60 mV increased in hT solution by 31.4 ± 8.2% from 8.2 ± 1.1
pNpF to 10.4 ± 2.5 pNpF, n = 10, P < 0.001. Addition of 10 ILM azimilide
(NE-10064), a potent blocker of IKs ' inhibited the time-dependent outward
current at 60 mV by 82.0 ± 5.3%, n = 10, p = 0.002. The initial current at 60
mV was increased in hT solution by 4.1 ± 2.2 pNpF. This initial current was
partially inhibited by the CI- channel blocker, DIDS, and was not effected by
10 ILM azimilide. In CI--free hT solutions, IKs increased to a similar degree
as in CI--containing solutions (46.8 ± 16.8%, n = 4, p = 0.05). No increase
in the initial current was observed in CI- -free hT solutions.
Conclusions: Hypotonic-induced stretch upregulates IKs and a CI- current
and underlies the APD shortening which occurs with stretch. The increase
in these repolarizing currents with stretch antagonizes the APD prolonging
effect of the d-sotalol analogue, E-4031.
reached 5.6 ± 1.3 and 4.4 ± 0.7 mV for Groups 1-2, respectively (CL 990
ms). After 10 min exposure to E or 0, DAD amplitude increased to 6.6 ± 1.3
and 6.5 ± 1.0 mY, respectively (p < 0.05). In Group 3, after switching from
AS to no drug for 10 min, DAD amplitude was decreased by 2.2 ± 0.5 mV (p
< 0.05). Similar findings were obtained at the 690 ms CL. 2) E and 0 exerted
a biphasic effect on APD, initially shortening it at 10 min of exposure (p <
0.05) before it lengthened. 3) E and 0 prolonged DAD disappearance time
(36.0 ± 2.4, 34.0 ± 8.7, and 16.0 ± 2.4 min in Groups 1-3, respectively). 4)
E and 0 occasionally induced triggered action potentials. Lowering [K]o (5.4
to 4.0 mM) worsened these effects. 5) Without prior AS exposure, E caused
only prolongation of APD and occasionally the induction of early afterdepo-
larizations. Conclusions: E and 0 enhanced DADs and triggered activity. In
the presence of AS induced Ca2+ overload, E and 0 caused shortening of
APD. These effects can not be explained solely by selective block of iKR by E
and D. Additional drug effects, resembling enhancement of cardiac glycoside
toxicity, exist.
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1771-51 Stretch Antagonizes the Action Potential Prolonging
Effect of a Class III Antiarrhythmic Agent: Mechanism
of Action
286A ABSTRACfS JACC February 1995
2B.0 ± 4.2
10.7 ± B.6t
VC after
(% baseline)
25.7 ± 7.6
26.2 ± 72
VC before
1% baselinel
100
59.3 ± 14.0'
PLT deposition
1% control I
'p < 0.05 vs dextrose; tp < 0.05 vs VC before
Poly(organo)phosphazene polymer (PP) coated on metallic coronary stents
induce a severe histiolymphocytic and fibromuscular reaction leading to ma-
jor coronary stenosis 6 weeks after stent implantation in a porcine coro-
nary model. PP coated stents were loaded with angiopeptin (AP) (5 wt %)
and stent stenosis was evaluated using quantitative coronary analysis and
histopathology. A total of 14 pigs (7 received an AP loaded stent, 7 a non
AP loaded stent (NAP) were studied. Minimal luminal stent diameter (MLSD)
was measured using a semi-automated edge detection algorithm (Polytron<!>
1000 Siemens)
Pre stent implantation MLSD;APL:2.5 ± 0.2 mm; NAPL 2.6 ± 0.4 mm (NS).
Post stent implantation MLSD:APL:3.0 ± 0.4 mm; NAPL 3.4 ± 0.3 mm (NS).
After 6 weeks MLSD was significantly higher in the APL group compared
with the NAPL group 2.2 ± 0.6 mm vs 1.7 ± 1.0 mm (p < 0.01).
Histopathology demonstrated a severe histiolymphocytic and fibromus-
cular reaction in both groups but vessel narrowing was significantly more
important in the NAPL group compared with the APL group (87.6 ± 11.5%
vs 63.4 ± 18.2%; p < 0.01). These results suggest that local AP delivery
using an AP loaded polymer coated stent is able to inhibit the foreign body
reaction induced by poly(organo)phosphazene stent coatings.
Thus, local administration of NTG directly into the injured arterial wall is
effective in decreasing platelet deposition and the vasoconstrictive response
after deep arterial injury. This may improve vascular function after balloon
injury.
vessel was not heated. Arteries were harvested at one hour for scintillation
counting. In both the in vivo and in vitro studies, balloon inflations were at 6
atm for 2.5 minutes. In all heated vessels thermal energy was applied for 90
sees.
Results: Supplemental heating during local drug delivery significantly in-
creased both the immediate deposition and the persistence of intramurally
delivered heparin. In vitro, the heparin deposition score was 2.3 ± 0.5 for
heated arteries and 1.3 ± 0.8 for controls (p = < 0.03). In vivo, more heparin
was present at one hour in the heated arteries than in the control arteries in
11 of 13 vessel pairs (heated vessels, 58 ± 46 units; non-heated controls, 43
± 42 units, p = 0.02).
Conclusion: Vascular heating at the time of local heparin delivery with
hydrogei-coated balloons increases both the immediate delivery and the per-
sistence of heparin in the arterial wall.
Dextrose
NTG
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Anglopeptln Loaded Stents Inhibit the Neointimal
Reaction Induced by Polymer Coated Stents
Implanted In Porcine Coronary Arteries
Ivan K. De Scheerder, Krysztof L. Wilczek, Joke Van Dorpe, Walter Desmet,
Eric Verbeken, Seedabarum CathapermaJ. Etienne Schacht, Jan H. Piessens,
Marie Foegh UH Gasthuisberg, Leuven, Belgium
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Local Intramural Nitroglycerin Delivery Improves
Vascular Responses to Balloon Arterial Injury
Daniel Hebert, Jules YT. Lam, Alvaro Moura, Aaron V Kaplan Montreal Heart
Institute, Montreal, Quebec, Canada
Endothelial denuding injury of the arterial wall in vivo is associated with a lo-
calized platelet deposition and a vasoconstrictive response, that may be due
to loss of endogenous vessel wall EDRF nitric oxide production. Exogenous
administration of EDRF in the form of systemic nitroglycerin (NTG) can de-
crease the injury-related platelet deposition and vasoconstriction. Whether
the injured vessel wall EDRF effect can be enhanced by local intramural NTG
delivery was studied using a Localmed infusion sleeve. Normal pigs under-
went carotid arterial injury by a balloon dilatation catheter placed inside a
sleeve with distal micro-perforations designed for intramural drug delivery at
the site of angioplasty. In 6 pigs, the left carotid was treated with NTG, while
the right carotid was treated with dextrose 5% vehicle. Autologous 51 Cr-
platelet (PLT) deposition quantified at the site of deep arterial injury by the
body of the balloon, and the degree of angiographic vasoconstriction (VC) at
the site of endothelial denudation by the tapering ends of the balloon, were
assessed before and after NTG or dextrose delivery, and are shown below,
(mean ± SEM):
Group
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Heparin Delivery at the Site of Angloplasty with a
Novel Drug Delivery Sleeve: Initial Clinical Series
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In conclusion administration of radiolabelled drugs allows to assess local
pharmacokinetics and to quantify local drug retention-time and local retained
amount of drug.
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accumulation was observed for Tc-99m Hand In-l11 0 (linear fitting: H: r =
0.97 ± 0.02; 0: r = 0.98 ± 0.02) followed at infusion stop by a biexponential
washout (biexponential fitting: H: r = 0.96 ± 0.02; 0: r = 0.98 ± 0.02). Lo-
cal retention time, defined as 5 concentration half-lives and derived from the
2nd slow washout phase, thought to reflect tissular washout, was for H 18
± 2 h and for a 7 ± 3 h. Of the totally infused dose for H 6.8% and 0.5% (123
and 11 IU; 644 and 58 Itg) and for 00.3% ± 0.2% (0.55 ± 0.37 ng) remained
at the site of delivery.
Daniel B. Fram, Joseph F. Mitchel, Hans H. Bauer, Susan M. Ropiak, David
D. Waters, Raymond G. McKay Hartford Hospital, University of Connecticut. Hartford,
CT
Although previous studies have demonstrated that heparin can be deliv-
ered to the arterial wall during balloon angioplasty with hydrogel-coated bal-
loons, drug washout over the first hour is rapid. The purpose of this study
was to determine whether vascular heating during local heparin delivery
with hydrogel-coated, radiofrequency-powered thermal angioplasty balloons
would affect immediate drug deposition and the subsequent persistence of
heparin within the arterial wall. To evaluate the effect ofheat on heparin de-
position, fluorescein-labeled heparin was delivered in vitro to 13 bovine coro-
nary arteries either at 50'C (n = 3), at 60'C (n = 3) or without heat (n = 7).
Heparin deposition was graded on a 1-3 scale as extending into the inner 1/3,
the middle 113 or outer 113 of the arterial wall. To assess the effect ofheat on
the intramural persistence ofheparin, 3H-heparin was delivered in vivo to 13
porcine peripheral artery pairs. The balloon:artery ratio was 1.2: 1 as guided
by intravascular ultrasound. One artery in each pair was heated during hep-
arin delivery to either 50'C (n = 11) or 80'C (n = 2). The contralateral control
Aaron V Kaplan, Michel Vandormael, Antonio Bartorelli, Manfred Hofmann,
Hans Stoerger, John B. Simpson, Nicolaus Reifart. Red Cross Hospital & Heart
Cente" Frankfurt, Germany: Instituto di Cardi%gia, Fondazione Monzino, Milan, Italy
The LocalMed InfusaSleeve (IS) is a multi-lumen array with distal micro per-
forations designed to deliver agent at the site of angioplasty. Prior to the
procedure, the IS is loaded onto a standard dilatation catheter (DC). Using
standard technique, angioplasty is performed with the IS retracted. After le-
sion dilatation, the IS is tracked over the DC, aligning the micro perforation
region of the IS with the balloon. The balloon is reinflated bringing the array
into close proximity to the arterial wall. Agent(s) is delivered at specific pres-
sures independent of balloon inflation. We have previously shown that agent
delivery into the wall is dependent upon balloon inflation and drug delivery
pressures. A pilot series was performed to evaluate the safety of heparin
delivery via the IS.
A total of 21 patients [emergent/urgent (2), elective cases (19)] with lesions
at a variety of anatomic sites [LAD(10), LCx(3), ramus intermedius(l), RCA(6)
and vein graft (1)] and complexity [ACC/AHA Lesion Type: A(8), Bl(l 0), B2(3)]
were attempted. Following PTCA, heparin (1,000 U/ml) was delivered via the
IS into the arterial lumen (balloon inflation pressure = 0.5 atm, drug delivery
pressure = 40 psi). Failure to track the IS was noted in 2 cases. In 2 cases
(RCA) a dissection was noted following agent infusion [NHLBI Type: A(l),
B( 1)]. The IS was used in conjunction with standard guide catheters [8 fr (15),
9 fr (6)], DC and guide wires. At discharge, no complications were noted.
We Conclude: 1) The IS can be used safely at a variety of anatomic sites,
2) The IS is compatible with standard PTCA equipment. 3) Local delivery of
agent via LocalMed InfusaSleeve is a promising approach to reduce abrupt
closure and restenosis.
1772-41 Intravascular Heating Facilitates Local Heparin
Delivery and Attenuates Washout During Balloon
Angioplasty with Hydrogel-Coated Balloons
